AAAAAA
Results: 1-25/48
Authors:
Senard, JM
Brefel-Courbon, C
Rascol, O
Montastruc, JL
Citation: Jm. Senard et al., Orthostatic hypotension in patients with Parkinson's disease - Pathophysiology and management, DRUG AGING, 18(7), 2001, pp. 495-505
Authors:
Curnier, D
Galinier, M
Pathak, A
Fourcade, J
Bousquet, M
Senard, JM
Fauvel, JM
Bounhoure, JP
Montastruc, JL
Citation: D. Curnier et al., Rehabilitation of patients with congestive heart failure with or without beta-blockade therapy, J CARD FAIL, 7(3), 2001, pp. 241-248
Authors:
Sulem, P
Bagheri, H
Faixo, Y
Montastruc, JL
Citation: P. Sulem et al., Atorvastatin-induced diaphragmatic muscle impairment, ANN PHARMAC, 35(10), 2001, pp. 1292-1293
Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease
Authors:
Rascol, O
Arnulf, I
Paul, HPS
Brefel-Courbon, C
Vidailhet, M
Thalamas, C
Bonnet, AM
Descombes, S
Bejjani, B
Fabre, N
Montastruc, JL
Agid, Y
Citation: O. Rascol et al., Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease, MOVEMENT D, 16(4), 2001, pp. 708-713
Authors:
Montastruc, JL
Rascol, O
Citation: Jl. Montastruc et O. Rascol, Modafinil and pramipexole-associated somnolence, MOVEMENT D, 16(4), 2001, pp. 783-783
Authors:
Montastruc, JL
Desboeuf, K
Lapeyre-Mestre, M
Senard, JM
Rascol, O
Brefel-Courbon, C
Citation: Jl. Montastruc et al., Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease, MOVEMENT D, 16(3), 2001, pp. 511-514
Authors:
Pelat, M
Verwaerde, P
Tran, MA
Berlan, M
Senard, JM
Montastruc, JL
Citation: M. Pelat et al., Changes in vascular alpha1-and alpha2-adrenoceptor responsiveness by selegiline treatment, FUN CL PHAR, 15(4), 2001, pp. 239-245
Authors:
Montastruc, JL
Brefel-Courbon, C
Senard, JM
Bagheri, H
Ferreira, J
Rascol, O
Lapeyre-Mestre, M
Citation: Jl. Montastruc et al., Sleep attacks and antiparkinsonian drugs: A pilot prospective pharmacoepidemiologic study, CLIN NEUROP, 24(3), 2001, pp. 181-183
Authors:
Ferreira, JJ
Thalamas, C
Montastruc, JL
Castro-Caldas, A
Rascol, O
Citation: Jj. Ferreira et al., Levodopa monotherapy can induce "sleep attacks" in Parkinson's disease patients, J NEUROL, 248(5), 2001, pp. 426-427
Authors:
Rascol, O
Ferreira, J
Montastruc, JL
Citation: O. Rascol et al., Abnormal daytime somnolence, "sleep attacks", and antiparkinson drugs, REV NEUROL, 157(10), 2001, pp. 1313-1323
Authors:
Descombes, S
Brefel-Courbon, C
Thalamas, C
Albucher, JF
Rascol, O
Montastruc, JL
Senard, JM
Citation: S. Descombes et al., Amitriptyline treatment in chronic drug-induced headache: A double-blind comparative pilot study, HEADACHE, 41(2), 2001, pp. 178-182
Authors:
Amouyal-Barkate, K
Bagheri-Charabiani, H
Montastruc, JL
Moulias, S
Vellas, B
Citation: K. Amouyal-barkate et al., Abnormal movements with donepezil in Alzheimer disease, ANN PHARMAC, 34(11), 2000, pp. 1347-1347
Authors:
Brefel-Courbon, C
Thalamas, C
Rascol, O
Montastruc, JL
Senard, JM
Citation: C. Brefel-courbon et al., Lack of autonomic nervous dysfunction in progressive supranuclear palsy, astudy of blood pressure variability, CLIN AUTON, 10(5), 2000, pp. 309-312
Authors:
Montastruc, JL
Citation: Jl. Montastruc, Treatment of Parkinson's disease should begin with a dopamine agonist, MOVEMENT D, 15(2), 2000, pp. 361-362
Authors:
Lazartigues, E
Brefel-Courbon, C
Bagheri, H
Costes, S
Gharib, C
Tran, MA
Senard, JM
Montastruc, JL
Citation: E. Lazartigues et al., Fluoxetine-induced presser response in freely moving rats: a role for vasopressin and sympathetic tone, FUN CL PHAR, 14(5), 2000, pp. 443-451
Authors:
Montastruc, JL
Chaumerliac, C
Desboeuf, K
Manika, M
Bagheri, H
Rascol, O
Lapeyre-Mestre, M
Citation: Jl. Montastruc et al., Adverse drug reactions to selegiline: A review of the French Pharmacovigilance Database, CLIN NEUROP, 23(5), 2000, pp. 271-275
Authors:
Brefel-Courbon, C
Simonetta-Moreau, M
More, C
Rascol, O
Clanet, M
Montastruc, JL
Lapeyre-Mestre, M
Citation: C. Brefel-courbon et al., A pharmacoeconomic evaluation of botulinum toxin in the treatment of spasmodic torticollis, CLIN NEUROP, 23(4), 2000, pp. 203-207
Authors:
Thalamas, C
Galitzky, J
Senard, JM
Lafontan, M
Montastruc, JL
Berlan, M
Barbe, P
Citation: C. Thalamas et al., Glucose-induced sympathetic activity and energy expenditure during acute alpha(2)-adrenergic antagonism in obese subjects, INT J OBES, 24(6), 2000, pp. 695-700
Authors:
Bagheri, H
Michel, F
Lapeyre-Mestre, M
Lagier, E
Cambus, JP
Valdiguie, P
Montastruc, JL
Citation: H. Bagheri et al., Detection and incidence of drug-induced liver injuries in hospital: a prospective analysis from laboratory signals, BR J CL PH, 50(5), 2000, pp. 479-484
Authors:
Ferreria, J
Galitzky, M
Montastruc, JL
Rascol, O
Citation: J. Ferreria et al., Sleep attacks in Parkinson's disease - Reply, LANCET, 356(9229), 2000, pp. 598-598
Authors:
Ferreira, JJ
Galitzky, M
Montastruc, JL
Rascol, O
Citation: Jj. Ferreira et al., Sleep attacks and Parkinson's disease treatment, LANCET, 355(9212), 2000, pp. 1333-1334
Authors:
Bagheri, H
Lhiaubet, V
Montastruc, JL
Chouini-Lalanne, N
Citation: H. Bagheri et al., Photosensitivity to ketoprofen - Mechanisms and pharmacoepidemiological data, DRUG SAFETY, 22(5), 2000, pp. 339-349
Authors:
Pelagatti, V
Bagheri, H
Fernandez, P
Railhac, N
Bregeon, C
Railhac, JJ
Montastruc, JL
Citation: V. Pelagatti et al., Adverse drug effects of iodinated contrast agents: a six-month study in a radiology department, THERAPIE, 55(3), 2000, pp. 391-394
Authors:
Remy, N
Lapeyre-Mestre, M
Bareille, MP
Bagheri, H
Montastruc, JL
Citation: N. Remy et al., Drug interactions: a prospective pilot study in primary health care, THERAPIE, 55(3), 2000, pp. 395-398
Authors:
Bagheri, H
Frelezeau, F
Montastruc, JL
Citation: H. Bagheri et al., Adverse drug reactions in topically applied drugs, THERAPIE, 55(1), 2000, pp. 211-219